DZD6008 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of an offshore drilling rig near Namibia’s coast at sunset, illustrating bp plc’s entry into the Walvis Basin through its Eco Atlantic Oil & Gas block acquisition.

ONGC gives Transocean $300m India contract that could keep KG2 busy into 2031

Vitestro’s Aletta robotic blood-draw system has received U.S. Food and Drug Administration De Novo authorization, opening a new regulatory pathway for autonomous phlebotomy as laboratories weigh whether robotic blood collection can scale economically and operationally. Representative image.

Vitestro wins FDA De Novo authorization for Aletta robotic blood draw system

Baidu’s second-quarter 2026 results highlight the tension in its AI transition, with AI Cloud Infrastructure revenue rising 50% and GPU Cloud revenue surging 283% even as legacy businesses weakened and total revenue declined 4%. Representative image.

Baidu GPU cloud surges 283%, but investors punish unfinished AI transition

A66 wrong-way crash kills seven including two Cleveland Police officers near Middlesbrough

Representative image: Researchers review lung cancer imaging data as Dizal Pharmaceutical Co., Ltd.’s ASCO 2026 update highlights new NSCLC clinical signals for DZD6008 and golidocitinib.

Read More

Pharma Industry News

Dizal Pharmaceutical deepens NSCLC pipeline case as DZD6008 and golidocitinib data sharpen ASCO 2026 focus

Read how Dizal’s ASCO 2026 NSCLC data for DZD6008 and golidocitinib could reshape its lung cancer pipeline strategy today!

May 31, 2026

web analytics